Id |
Subject |
Object |
Predicate |
Lexical cue |
T74 |
0-4 |
Sentence |
denotes |
2.2. |
T75 |
5-43 |
Sentence |
denotes |
Investigated SARS-CoV-2 Antibody Tests |
T76 |
44-724 |
Sentence |
denotes |
Seven SARS-CoV-2 IgG assays (Abbott SARS-CoV-2 IgG, Wiesbaden, Germany; DiaSorin Liaison® SARS-CoV-2 S1/2 IgG, DiaSorin, Dietzenbach, Germany; Epitope EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit, Epitope Diagnostics, San Diego, CA, USA; Euroimmun Anti-SARS-CoV-2 ELISA (IgG), EUROIMMUN AG, Lübeck, Germany; Mikrogen recomWell SARS-CoV-2 IgG, Mikrogen GmbH, Neuried, Germany; SARS-CoV-2 ViraChip® IgG Test, Viramed Biotech AG, Planegg, Germany; and SERION ELISA agile SARS-COV-2 IgG, Institute Virion-Serion GmbH, Würzburg, Germany), as well as one total SARS-CoV-2 antibody test (Roche Elecsys Anti-SARS-CoV-2, Roche Diagnostics, Mannheim, Germany), were included in this study. |
T77 |
725-947 |
Sentence |
denotes |
The recombinant antigens of these tests cover the N protein (Abbott, Epitope, Mikrogen, Roche) and the entire S protein (Virion-Serion), as well as its S1 domain alone (Euroimmun) or together with the S2 domain (DiaSorin). |
T78 |
948-1149 |
Sentence |
denotes |
The SARS-CoV-2 ViraChip® IgG test kit uses the purified viral surface antigens S1 and S2 and the N antigen, which are all presented separately at a defined position on a nitrocellulose film (Table S1). |
T79 |
1150-1491 |
Sentence |
denotes |
All tests were conducted strictly following the recommendations of the manufacturers on an Architect or Alinity machine (Abbott), a Liaison XL (DiaSorin), or a Cobas e 411 (Roche) or, for the assays of Epitope, Euroimmun, Mikrogen Viramed, and Virion-Serion, on the BEP 2000 system (Siemens Healthcare GmbH, Erlangen, Germany), respectively. |
T80 |
1492-1601 |
Sentence |
denotes |
The ViraChip® test was then evaluated automatically by help of a ViraChip® reader and the ViraChip® Software. |
T81 |
1602-1660 |
Sentence |
denotes |
All borderline/gray zone results were counted as positive. |
T82 |
1661-1795 |
Sentence |
denotes |
Furthermore, raw data from seven assays were converted into relative indices according to the decision limits set by the manufacturer. |
T83 |
1796-1929 |
Sentence |
denotes |
Thereby, a signal (S)/cut-off (CO) value of <1 was valued as negative and ≥1 as positive, which corresponds to a previous study [22]. |
T84 |
1930-2073 |
Sentence |
denotes |
Results of the SARS-CoV-2 ViraChip® IgG could not be converted into relative indices and were only given qualitatively as negative or positive. |
T85 |
2074-2213 |
Sentence |
denotes |
The proportion of correctly identified samples per test relative to the chosen reference method was calculated and given as assay accuracy. |
T86 |
2214-2379 |
Sentence |
denotes |
The convalescent sera were also tested with and without avidity reagent (contains urea in denaturating concentrations) in two versions of an IgG line assay (blot v1: |
T87 |
2380-2449 |
Sentence |
denotes |
Mikrogen recomLine Coronavirus IgG (Avidität), prototype and blot v2: |
T88 |
2450-2500 |
Sentence |
denotes |
Mikrogen recomLine SARS-CoV-2 IgG (Avidität)/RUO). |
T89 |
2501-2724 |
Sentence |
denotes |
The first version is based on the N protein of the human coronaviruses (HCoVs) 229E, HKU1, NL63, and OC43, which are used separately as antigens, and on the N protein of the “classic” SARS-CoV from 2002/2003 and SARS-CoV-2. |
T90 |
2725-2885 |
Sentence |
denotes |
The second improved version still uses the N proteins of the aforementioned HCoVs and of SARS-CoV-2 but has been expanded to include the S1 antigen and its RBD. |
T91 |
2886-2941 |
Sentence |
denotes |
A Dynablot Plus system was used to process all samples. |
T92 |
2942-3051 |
Sentence |
denotes |
Blots were then evaluated automatically with a BLOTrix reader and the recomScan software (all from Mikrogen). |